Organizational and Management Impact Analysis of Using the New Subcutaneous Formulation of Tocilizumab in Selected Italian Rheumatology Centers
Abstract
Authors
S. Ravera R. Tomic S. Adami O. Viapiana D. Paolini L. Bianchino M. Canciani M. Farina G. Ciancio M. Govoni